Dr Reddy's was founded in 1984 by Dr K. Anji Reddy and under his leadership has become a global pharmaceutical company headquartered in India with products marketed in over 100 countries.
Our aim is to deliver to New Zealanders high quality generic medicines at affordable prices. We are able to achieve this by leveraging:
- our position as a significant global producer of active pharmaceutical ingredients.
- our state-of-the-art, certified manufacturing infrastructure with 13 facilities around the world including the US, India, UK and Germany.
- our team of qualified and experienced research and development professionals.
In addition to providing high quality, affordable generic medicines Dr Reddy's also aims to develop new treatments that satisfy unmet medical needs and are improvements over currently existing therapies.
Dr Reddy's has developed a combination therapy to prevent ischaemic heart disease, and is currently partnering with the University of Auckland Clinical Trials Research Unit in the polypill trial programme.
For further information on Dr. Reddy's Laboratories see www.drreddys.com
